BRD4 and acute myeloid leukemia: Co‐treatment with a novel BRD4 inhibitor (ACC010) and homoharringtonine (HHT) synergistically inhibited cell proliferation, induced apoptosis, and arrested the cell cycle in AML with FLT3‐ITD mutation.